vs

Side-by-side financial comparison of Vyome Holdings, Inc (HIND) and QMMM Holdings Ltd (QMMM). Click either name above to swap in a different company.

QMMM Holdings Ltd is the larger business by last-quarter revenue ($2.0M vs $1.2M, roughly 1.6× Vyome Holdings, Inc). QMMM Holdings Ltd runs the higher net margin — -7.1% vs -211.8%, a 204.6% gap on every dollar of revenue.

Vyome Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic solutions for a range of dermatological conditions. Its product pipeline targets unmet medical needs related to acne, atopic dermatitis, and chronic fungal infections, with primary operations and market presence across North America and South Asia.

HIND vs QMMM — Head-to-Head

Bigger by revenue
QMMM
QMMM
1.6× larger
QMMM
$2.0M
$1.2M
HIND
Higher net margin
QMMM
QMMM
204.6% more per $
QMMM
-7.1%
-211.8%
HIND

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
HIND
HIND
QMMM
QMMM
Revenue
$1.2M
$2.0M
Net Profit
$-2.6M
$-146.1K
Gross Margin
48.2%
27.1%
Operating Margin
-222.4%
-6.5%
Net Margin
-211.8%
-7.1%
Revenue YoY
-36.8%
Net Profit YoY
-64.9%
EPS (diluted)
$-2.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIND
HIND
QMMM
QMMM
Q2 25
$1.2M
Q1 25
$1.1M
$2.0M
Q4 24
$1.8M
Q3 24
$2.3M
Q2 24
$2.0M
Q1 24
$1.9M
$1.3M
Q4 23
$2.0M
Q3 23
$2.2M
Net Profit
HIND
HIND
QMMM
QMMM
Q2 25
$-2.6M
Q1 25
$1.5M
$-146.1K
Q4 24
$2.9M
Q3 24
$-547.8K
Q2 24
$-1.6M
Q1 24
$-2.2M
$-612.0K
Q4 23
$-1.7M
Q3 23
$-3.5M
Gross Margin
HIND
HIND
QMMM
QMMM
Q2 25
48.2%
Q1 25
61.2%
27.1%
Q4 24
-118.6%
Q3 24
1.6%
Q2 24
57.7%
Q1 24
59.9%
24.1%
Q4 23
92.9%
Q3 23
59.8%
Operating Margin
HIND
HIND
QMMM
QMMM
Q2 25
-222.4%
Q1 25
-198.2%
-6.5%
Q4 24
Q3 24
-12.3%
Q2 24
-104.5%
Q1 24
-113.7%
-46.2%
Q4 23
-95.7%
Q3 23
-180.0%
Net Margin
HIND
HIND
QMMM
QMMM
Q2 25
-211.8%
Q1 25
132.4%
-7.1%
Q4 24
160.0%
Q3 24
-23.9%
Q2 24
-81.2%
Q1 24
-112.8%
-45.5%
Q4 23
-85.7%
Q3 23
-164.0%
EPS (diluted)
HIND
HIND
QMMM
QMMM
Q2 25
$-2.25
Q1 25
$18.98
Q4 24
$-4355.36
Q3 24
$-1419.10
Q2 24
$-91.56
Q1 24
$-135.37
Q4 23
$-48.87
Q3 23
$-59.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIND
HIND
QMMM
QMMM
Cash + ST InvestmentsLiquidity on hand
$167.9K
Total DebtLower is stronger
Stockholders' EquityBook value
$-5.0M
$3.9M
Total Assets
$4.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIND
HIND
QMMM
QMMM
Q2 25
Q1 25
$2.5M
$167.9K
Q4 24
$101.9K
Q3 24
$743.0K
Q2 24
$12.0K
Q1 24
$2.4M
$218.9K
Q4 23
$4.5M
Q3 23
$1.4M
Stockholders' Equity
HIND
HIND
QMMM
QMMM
Q2 25
$-5.0M
Q1 25
$1.2M
$3.9M
Q4 24
$-4.4M
Q3 24
$1.5M
Q2 24
$-4.0M
Q1 24
$4.5M
$-1.1M
Q4 23
$-6.2M
Q3 23
$3.1M
Total Assets
HIND
HIND
QMMM
QMMM
Q2 25
Q1 25
$6.5M
$4.5M
Q4 24
$1.4M
Q3 24
$1.3M
Q2 24
$-614.0K
Q1 24
$8.2M
$1.3M
Q4 23
$10.7M
Q3 23
$7.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIND
HIND
QMMM
QMMM
Operating Cash FlowLast quarter
$-301.2K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIND
HIND
QMMM
QMMM
Q2 25
Q1 25
$-2.1M
$-301.2K
Q4 24
Q3 24
$1.5M
Q2 24
Q1 24
$-2.1M
$-184.6K
Q4 23
$-2.5M
Q3 23
$-2.8M
Capex Intensity
HIND
HIND
QMMM
QMMM
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
0.0%
Q3 23
0.0%
Cash Conversion
HIND
HIND
QMMM
QMMM
Q2 25
Q1 25
-1.44×
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons